Aidoc has received FDA Breakthrough Device Designation for First Read, an AI system designed to analyze chest X-rays and generate preliminary radiology report drafts. The technology is intended to help address growing imaging workloads by producing high-quality draft reports that radiologists can review and finalize, reducing the time spent on routine documentation while preserving clinician oversight. The designation recognizes technologies that address unmet clinical needs and may accelerate their regulatory review and availability.
The announcement comes as healthcare systems face increasing pressure from rising imaging volumes and worsening radiologist shortages. Recent research has shown that imaging interpretation turnaround times have increased substantially over the past decade, contributing to delays in diagnosis, emergency department throughput and overall patient care. Aidoc developed First Read to help ease these operational challenges by automating part of the reporting process, allowing radiologists to devote more time to clinical interpretation, decision-making and complex cases rather than administrative documentation.
First Read builds on Aidoc’s existing clinical AI platform, which is already deployed across nearly 2,000 hospitals and has analyzed more than 120 million patient cases. The new application is based on the same validated technology that powers the company’s FDA-cleared imaging triage tools and integrates directly into existing radiology and electronic medical record workflows. Aidoc says the platform is designed with safeguards to reduce the risks associated with generative AI, including maintaining clinician review and final approval of every report. The designation further strengthens the company’s position as it continues expanding its enterprise AI platform across health systems worldwide.
Click here to read the original news story.
